Neuberger Berman Group’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Sell |
23,234
-23,096
| -50% | -$3.99M | ﹤0.01% | 1018 |
|
|
2025
Q1 | $7.22M | Buy |
46,330
+8,201
| +22% | +$1.28M | 0.01% | 848 |
|
|
2024
Q4 | $5.25M | Sell |
38,129
-1,633
| -4% | -$225K | ﹤0.01% | 953 |
|
|
2024
Q3 | $5.94M | Buy |
39,762
+9,466
| +31% | +$1.41M | ﹤0.01% | 909 |
|
|
2024
Q2 | $4.13M | Buy |
+30,296
| New | +$4.13M | ﹤0.01% | 946 |
|
|
2021
Q2 | – | Sell |
-190,900
| Closed | -$24.6M | – | 1750 |
|
|
2021
Q1 | $24.6M | Buy |
190,900
+60,400
| +46% | +$7.78M | 0.02% | 630 |
|
|
2020
Q4 | $21.8M | Buy |
130,500
+2,500
| +2% | +$417K | 0.02% | 620 |
|
|
2020
Q3 | $19.8M | Buy |
128,000
+22,000
| +21% | +$3.4M | 0.02% | 583 |
|
|
2020
Q2 | $15.7M | Buy |
106,000
+46,500
| +78% | +$6.88M | 0.02% | 622 |
|
|
2020
Q1 | $6.7M | Sell |
59,500
-5,169
| -8% | -$582K | 0.01% | 743 |
|
|
2019
Q4 | $9M | Buy |
+64,669
| New | +$9M | 0.01% | 763 |
|
|
2018
Q2 | – | Sell |
-14,000
| Closed | -$916K | – | 1701 |
|
|
2018
Q1 | $916K | Buy |
+14,000
| New | +$916K | ﹤0.01% | 1196 |
|